What Sectoral Asset Management Inc reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1274413 · Filed Nov 13, 2026
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
| 689.6K |
| −5.2% |
| $9.3M |
| 5.9% |
SIShoulder Innovations, Inc. | 430.4K | +0.0% | $8.1M | 5.2% |
LLYEli Lilly & Co | 6.7K | +4.9% | $7.7M | 4.9% |
JNJJohnson & Johnson | 22.8K | +24.9% | $6M | 3.8% |
VRTXVertex Pharmaceuticals Inc | 7.5K | +38.7% | $3.9M | 2.5% |
GILDGilead Sciences, Inc. | 24.7K | +19.6% | $3.7M | 2.3% |
AMGNAmgen Inc | 7.9K | −14.7% | $3.3M | 2.1% |
ABBVAbbVie Inc. | 12.3K | +0.8% | $3.2M | 2% |
DXCMDexCom Inc | 37.2K | −26.6% | $3.2M | 2% |
SMMTSummit Therapeutics Inc. | 177.2K | −19.5% | $3M | 1.9% |
RCUSArcus Biosciences, Inc. | 115.9K | +4.6% | $3M | 1.9% |
MRKMerck & Co., Inc. | 20.5K | −4.7% | $3M | 1.9% |
BNTXBioNTech SE | 30.2K | −27.9% | $3M | 1.9% |
ORKAOruka Therapeutics, Inc. | 35.3K | −15.8% | $2.9M | 1.9% |
AVTXAvalo Therapeutics, Inc. | 177.3K | +47.8% | $2.7M | 1.7% |
INSMInsmed Inc | 23.7K | +2.1% | $2.7M | 1.7% |
AVBPArriVent BioPharma, Inc. | 87.3K | +10.5% | $2.6M | 1.7% |
TNGXTango Therapeutics, Inc. | 105.8K | New | $2.6M | 1.7% |
ARGXArgenx SE | 2.7K | −5.5% | $2.6M | 1.6% |
IRTCiRhythm Holdings, Inc. | 22.6K | −13.4% | $2.6M | 1.6% |
ATECAlphatec Holdings, Inc. | 246.2K | +32.4% | $2.5M | 1.6% |
CBIOCrescent Biopharma, Inc. | 167.6K | +38.2% | $2.4M | 1.6% |
BRVEBraveheart Bio, Inc. | 119.7K | New | $2.4M | 1.5% |
ISRGIntuitive Surgical Inc | 5.9K | +0.3% | $2.4M | 1.5% |
UNHUnitedHealth Group Inc | 6.2K | −53.1% | $2.3M | 1.4% |
REGNRegeneron Pharmaceuticals, Inc. | 2.9K | +32.3% | $2.2M | 1.4% |
SYKStryker Corp | 7.8K | +9.8% | $2.2M | 1.4% |
DHRDanaher Corp | 9.6K | ±0% | $2.1M | 1.4% |
ROIVRoivant Sciences Ltd. | 58.1K | −4.9% | $2.1M | 1.4% |
IMTXImmatics N.V. | 226K | +0.5% | $2M | 1.3% |
TMOThermo Fisher Scientific Inc. | 2.9K | −17.1% | $2M | 1.2% |
IQVIQVIA Holdings Inc. | 7K | −35.3% | $1.9M | 1.2% |
ALNYAlnylam Pharmaceuticals, Inc. | 7.4K | +219.7% | $1.8M | 1.2% |
ABTAbbott Laboratories | 18.1K | ±0% | $1.8M | 1.1% |
TECXTectonic Therapeutic, Inc. | 72.6K | +2.2% | $1.7M | 1.1% |
PFEPfizer Inc | 57.5K | +109.1% | $1.6M | 1% |
QUREuniQure N.V. | 62.4K | New | $1.5M | 1% |
UTHRUnited Therapeutics Corp | 2.7K | +96.7% | $1.5M | 0.9% |
ABVXAbivax S.A. | 14.6K | +522.3% | $1.4M | 0.9% |
TMDXTransMedics Group, Inc. | 16K | −27.3% | $1.3M | 0.8% |
PLSEPulse Biosciences, Inc. | 26.2K | −61.5% | $1.3M | 0.8% |
CVSCVS Health Corp | 13K | +0.3% | $1.1M | 0.7% |
MRNAModerna, Inc. | 5.3K | +21.8% | $1M | 0.6% |
CYTKCytokinetics Inc | 15.3K | −6.4% | $1M | 0.6% |
MDTMedtronic plc | 11.1K | ±0% | $965.8K | 0.6% |
VERAVera Therapeutics, Inc. | 28.6K | +11.7% | $922.6K | 0.6% |
ELVElevance Health, Inc. | 2K | New | $780K | 0.5% |
BMYBristol Myers Squibb Co | 12.1K | −43.0% | $752.6K | 0.5% |
CNCCentene Corp | 12K | +0.3% | $747.9K | 0.5% |
BSXBoston Scientific Corp | 14.7K | −59.5% | $643K | 0.4% |
NKTRNektar Therapeutics | 10.1K | ±0% | $612.2K | 0.4% |
EWEdwards Lifesciences Corp | 6.8K | −54.1% | $587.3K | 0.4% |
ASNDAscendis Pharma A/S | 2.6K | ±0% | $585.5K | 0.4% |
ILMNIllumina, Inc. | 2.1K | ±0% | $583.5K | 0.4% |
BMRNBioMarin Pharmaceutical Inc | 9.5K | ±0% | $567K | 0.4% |
RVMDRevolution Medicines, Inc. | 2.8K | +50.8% | $566.5K | 0.4% |
PTCTPTC Therapeutics, Inc. | 8.6K | +14.7% | $555.2K | 0.4% |
HUMHumana Inc | 1.3K | +0.4% | $478.9K | 0.3% |
RPRXRoyalty Pharma plc | 7.2K | ±0% | $420.2K | 0.3% |
BIIBBiogen Inc. | 1.9K | ±0% | $417.9K | 0.3% |
GMABGenmab A/S | 9.9K | New | $353.2K | 0.2% |
GHGuardant Health, Inc. | 2K | ±0% | $353.2K | 0.2% |
IONSIonis Pharmaceuticals Inc | 7.2K | ±0% | $321.5K | 0.2% |
TEMTempus AI, Inc. | 3.9K | ±0% | $317.8K | 0.2% |
ORICOric Pharmaceuticals, Inc. | 23.5K | ±0% | $316.5K | 0.2% |
INCYIncyte Corp | 2.4K | ±0% | $285.2K | 0.2% |
AXSMAxsome Therapeutics, Inc. | 1.5K | ±0% | $276.6K | 0.2% |
NAMSNewAmsterdam Pharma Co N.V. | 9.5K | New | $231K | 0.1% |
ARDXArdelyx, Inc. | 56.1K | −54.2% | $191.9K | 0.1% |
CRBPCorbus Pharmaceuticals Holdings, Inc. | 28K | +40.0% | $191K | 0.1% |
KURAKura Oncology, Inc. | 17.1K | −76.1% | $182.6K | 0.1% |
SPRYARS Pharmaceuticals, Inc. | 40.3K | +34.8% | $173.7K | 0.1% |
NBIXNeurocrine Biosciences Inc | 1.2K | New | $163.1K | 0.1% |
ALXOALX Oncology Holdings Inc | 90K | New | $125.1K | 0.1% |
PALIPalisade Bio, Inc. | 88K | ±0% | $118.8K | 0.1% |
EYPTEyePoint, Inc. | 23.7K | New | $77.5K | 0.1% |
ENGNenGene Therapeutics Inc. | 21.7K | ±0% | $43.4K | 0.1% |